|Quantity Discounts||1 - 2|
|3 - 4|
|5 - 6|
|7 - 9|
|10 - 9999|
Pharmacovigilance in the EU: Expert Guidance on the Latest Rules and Directives
New EU directives were put in force in 2012 and compliance has become an issue. Last year saw 19 companies cited for “critical pharmacovigilance failures.” New directives were also recently adopted on postmarket studies as well as a rule on monitoring medical literature.
What can you do?
Join Elisabethann Wright, BL — partner in the Brussels, Belgium office of Hogan Lovells International — for a 90-minute session discussing current EU rules. She will cover the following issues:
Order today and stay on top of the most recent EU pharmacovigilance directives.
Elisabethann Wright, BL is a partner in the Brussels, Belgium office of Hogan Lovells International. Her experience is in the area of European law and has included both periods in private practice and periods working with international institutions. She focuses on European Union (EU) law relating to life sciences, with particular emphasis on pharmaceutical law, medical devices, food law and the environment.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing